Safety Evaluation of the Coagulase-Negative Staphylococci Microbiota of Salami: Superantigenic Toxin Production and Antimicrobial Resistance
Table 4
Minimal inhibitory concentration (MIC) of compounds used in antimicrobial therapy against staphylococci infections.
Salami origin
GenBank accession number and similarity (%)
MIC mg mL−1
Methicillin
Ampicillin
Vancomycin
Linezolid
Commercial
S. carnosus KJ862002.1
0.06
0.03
—
—
S. xylosus CP008724.1
0.06
0.03
0.06
—
S. saprophyticus JX490122.1
0.06
0.03
0.5
—
S. saprophyticus AB697717.1
—
—
0.5
—
S. saprophyticus EU430992.1
—
—
0.25
0.125
S. succinus KC329824.1
0.06
0.25
0.03
—
Artisanal
S. hominis. JX519988.1
0.06
0.5
—
—
S. saprophyticus HF937252.1
0.03
—
—
—
S. xylosus KF198080.1
0.03
0.5
—
S. saprophyticus KJ699151.1
0.5
0.25
0.03
—
S. saprophyticus KJ004623.1
0.5
0.03
0.03
—
S. xylosus CP007208.1
0.06
—
—
0.25
Strains S. epidermidis KF600589.1 and Staphylococcus spp. KF135445.1 were not susceptible to the antimicrobial concentrations tested in the present study.